Product NDC: | 63304-562 |
Proprietary Name: | Acetaminophen and Codeine Phosphate |
Non Proprietary Name: | Acetaminophen and Codeine Phosphate |
Active Ingredient(s): | 300; 30 mg/1; mg/1 & nbsp; Acetaminophen and Codeine Phosphate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63304-562 |
Labeler Name: | Ranbaxy Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA085868 |
Marketing Category: | ANDA |
Start Marketing Date: | 19781116 |
Package NDC: | 63304-562-05 |
Package Description: | 500 TABLET in 1 BOTTLE (63304-562-05) |
NDC Code | 63304-562-05 |
Proprietary Name | Acetaminophen and Codeine Phosphate |
Package Description | 500 TABLET in 1 BOTTLE (63304-562-05) |
Product NDC | 63304-562 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Acetaminophen and Codeine Phosphate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19781116 |
Marketing Category Name | ANDA |
Labeler Name | Ranbaxy Pharmaceuticals Inc. |
Substance Name | ACETAMINOPHEN; CODEINE PHOSPHATE |
Strength Number | 300; 30 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |